Singapore markets close in 3 hours 14 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
13.82-0.04 (-0.29%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 544.24B
Enterprise value 376.93B
Trailing P/E 11.76
Forward P/E 18.78
PEG Ratio (5 yr expected) 10.12
Price/sales (ttm)1.52
Price/book (mrq)0.97
Enterprise value/revenue 30.02
Enterprise value/EBITDA 70.07

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-13.35%
S&P500 52-week change 337.51%
52-week high 319.97
52-week low 313.81
50-day moving average 315.61
200-day moving average 316.53

Share statistics

Avg vol (3-month) 32.2M
Avg vol (10-day) 31.95M
Shares outstanding 53.15B
Implied shares outstanding 6N/A
Float 83.14B
% held by insiders 10.01%
% held by institutions 13.07%
Shares short (14 Oct 2021) 48.4M
Short ratio (14 Oct 2021) 42.76
Short % of float (14 Oct 2021) 4N/A
Short % of shares outstanding (14 Oct 2021) 40.27%
Shares short (prior month 14 Sep 2021) 46.24M

Dividends & splits

Forward annual dividend rate 40.84
Forward annual dividend yield 46.04%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 31,298.70%
5-year average dividend yield 44.14
Payout ratio 466.02%
Dividend date 314 Dec 2009
Ex-dividend date 429 Mar 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2021
Most-recent quarter (mrq)29 Jun 2021


Profit margin 12.89%
Operating margin (ttm)16.04%

Management effectiveness

Return on assets (ttm)2.65%
Return on equity (ttm)8.69%

Income statement

Revenue (ttm)3.35T
Revenue per share (ttm)1,069.84
Quarterly revenue growth (yoy)18.40%
Gross profit (ttm)2.2T
Net income avi to common (ttm)431.18B
Diluted EPS (ttm)1.20
Quarterly earnings growth (yoy)66.90%

Balance sheet

Total cash (mrq)684.85B
Total cash per share (mrq)217.75
Total debt (mrq)4.41T
Total debt/equity (mrq)84.10
Current ratio (mrq)1.45
Book value per share (mrq)1,665.55

Cash flow statement

Operating cash flow (ttm)1.03T
Levered free cash flow (ttm)913.05B